v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash $ 1,369,586 $ 2,856,309
Rent receivable 81,854 80,829
Receivable from sale of equity method investment, current portion 975,000
Prepaid expense and other current assets 367,818 299,360
Total Current Assets 2,794,258 3,236,498
NON-CURRENT ASSETS:    
Operating lease right-of-use assets, net 113,253 4,709
Receivable from sale of equity method investment, noncurrent portion 675,000
Property and equipment, net 10,660 12,912
Investment in real estate, net 6,980,551 7,022,721
Equity method investments, net 10,636,544
Other non-current assets 36,067 71,794
Total Non-current Assets 7,815,531 17,748,680
Total Assets 10,609,789 20,985,178
CURRENT LIABILITIES:    
Accrued professional fees 984,869 611,462
Accrued research and development fees 153,772 153,772
Accrued payroll liability and compensation 550,931 501,258
Accrued litigation settlement 373,450 373,450
Accrued liabilities and other payables 524,872 434,117
Operating lease obligation, current portion 67,547 10,709
Derivative liability 223,052 127,545
Note payable, net 5,745,254 5,715,447
Convertible note payable, net 2,397,528 2,113,773
Total Current Liabilities 14,449,353 13,882,555
NON-CURRENT LIABILITIES:    
Operating lease obligation, noncurrent portion 51,706
Total Non-current Liabilities 51,706
Total Liabilities 14,501,059 13,882,555
Commitments and Contingencies (Note 15)
(DEFICIT) EQUITY:    
Preferred stock, Value
Common stock, $0.0001 par value; 100,000,000 shares authorized;    
Common stock, $0.0001 par value; 100,000,000 shares authorized; 1,655,134 shares issued and 1,651,667 shares outstanding at March 31, 2025; 1,445,979 shares issued and 1,442,512 shares outstanding at December 31, 2024 166 145
Additional paid-in capital 74,673,916 72,023,525
3,467 shares at March 31, 2025 and December 31, 2024 (522,500) (522,500)
Accumulated deficit (90,155,236) (87,673,125)
Statutory reserve 6,578 6,578
Accumulated other comprehensive loss (231,721) (232,000)
Total Avalon GloboCare Corp. stockholders’ (deficit) equity (3,891,270) 7,102,623
Noncontrolling interest
Total (Deficit) Equity (3,891,270) 7,102,623
Total Liabilities and (Deficit) Equity 10,609,789 20,985,178
Series A Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 9,000,000
Series B Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 11,000,000
Series C Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 3,500,000 3,500,000
Series D Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 8,837,527
Related Party    
CURRENT LIABILITIES:    
Accrued liabilities and other payables - related parties 100,000 732,916
Advance from pending sale of noncontrolling interest - related party $ 3,328,078 $ 3,108,106

Source

PDF HTML
ZIP